PetMed Express, Inc is a pharmaceutical retailers business based in the US. PetMed Express shares (PETS) are listed on the NASDAQ and all prices are listed in US Dollars. PetMed Express employs 219 staff and has a trailing 12-month revenue of around 0.00.
How to buy shares in PetMed Express
- Compare share trading platforms.Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – PETS – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
What's in this guide?
- PETS shares summary
- Compare share dealing platforms
- Is PETS stock a buy or sell?
- Stock performance over time
- Can I short PETS shares?
- Are PETS shares over-valued?
- PetMed Express's financials
- How volatile are PETS shares?
- Does PetMed Express pay a dividend?
- Have PETS shares ever split?
- Other common questions
PetMed Express stock price (NASDAQ: PETS)Use our graph to track the performance of PETS stocks over time.
PetMed Express shares at a glance
|Latest market close||$28.90|
|52-week range||$24.75 - $55.98|
|50-day moving average||$31.72|
|200-day moving average||$32.81|
|Wall St. target price||$31.50|
|Dividend yield||$1.14 (3.71%)|
|Earnings per share (TTM)||$1.35|
Buy PetMed Express shares from these brokeragesCompare special offers, low fees and a wide range of types of investments among top trading platforms.
*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy PetMed Express stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
PetMed Express price performance over time
|1 week (2021-07-22)||N/A|
|1 month (2021-07-02)||-10.53%|
|3 months (2021-04-30)||-1.78%|
|6 months (2021-01-29)||N/A|
|1 year (2020-07-29)||N/A|
|2 years (2019-07-29)||N/A|
|3 years (2018-07-29)||N/A|
|5 years (2016-07-29)||N/A|
Is PetMed Express under- or over-valued?
Valuing PetMed Express stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of PetMed Express's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
PetMed Express's P/E ratio
PetMed Express's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 23x. In other words, PetMed Express shares trade at around 23x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
PetMed Express's PEG ratio
PetMed Express's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 2.58. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into PetMed Express's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
PetMed Express's EBITDA
PetMed Express's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $36.1 million.
The EBITDA is a measure of a PetMed Express's overall financial performance and is widely used to measure a its profitability.
PetMed Express financials
|Revenue TTM||$292.3 million|
|Operating margin TTM||11.48%|
|Gross profit TTM||$89.9 million|
|Return on assets TTM||12.49%|
|Return on equity TTM||19.96%|
|Market capitalisation||$621.5 million|
TTM: trailing 12 months
Shorting PetMed Express shares
There are currently 4.7 million PetMed Express shares held short by investors – that's known as PetMed Express's "short interest". This figure is 8.7% up from 4.3 million last month.
There are a few different ways that this level of interest in shorting PetMed Express shares can be evaluated.
PetMed Express's "short interest ratio" (SIR)
PetMed Express's "short interest ratio" (SIR) is the quantity of PetMed Express shares currently shorted divided by the average quantity of PetMed Express shares traded daily (recently around 486146.95562436). PetMed Express's SIR currently stands at 9.69. In other words for every 100,000 PetMed Express shares traded daily on the market, roughly 9690 shares are currently held short.
However PetMed Express's short interest can also be evaluated against the total number of PetMed Express shares, or, against the total number of tradable PetMed Express shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case PetMed Express's short interest could be expressed as 0.23% of the outstanding shares (for every 100,000 PetMed Express shares in existence, roughly 230 shares are currently held short) or 0.2413% of the tradable shares (for every 100,000 tradable PetMed Express shares, roughly 241 shares are currently held short).
A SIR below 10% would generally be considered to indicate a fairly optimistic outlook for the share price, with fewer people currently willing to bet against PetMed Express.
Find out more about how you can short PetMed Express stock.
PetMed Express share dividends
Dividend payout ratio: 1.02% of net profits
Recently PetMed Express has paid out, on average, around 1.02% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 4.03% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), PetMed Express shareholders could enjoy a 4.03% return on their shares, in the form of dividend payments. In PetMed Express's case, that would currently equate to about $1.14 per share.
While PetMed Express's payout ratio might seem low, this can signify that PetMed Express is investing more in its future growth.
PetMed Express's most recent dividend payout was on 20 May 2021. The latest dividend was paid out to all shareholders who bought their shares by 12 May 2021 (the "ex-dividend date").
Have PetMed Express's shares ever split?
PetMed Express's shares were split on a 3:1 basis on 3 March 1999. So if you had owned 1 share the day before before the split, the next day you'd have owned 3 shares. This wouldn't directly have changed the overall worth of your PetMed Express shares – just the quantity. However, indirectly, the new 66.7% lower share price could have impacted the market appetite for PetMed Express shares which in turn could have impacted PetMed Express's share price.
PetMed Express share price volatility
Over the last 12 months, PetMed Express's shares have ranged in value from as little as $24.75 up to $55.9832. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while PetMed Express's is 0.5816. This would suggest that PetMed Express's shares are less volatile than average (for this exchange).
PetMed Express overview
PetMed Express, Inc. , together with its subsidiaries, doing business as 1-800-PetMeds, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, and other health products for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, strollers, and other pet supplies. It sells its products through its Internet website and mobile app; telephone contact center; and direct mail/print through catalogs, brochures, and postcards. PetMed Express, Inc.
Stocks similar to PetMed Express
PetMed Express in the news
Dividend Champion And Contender Highlights: Week Of August 1
PetMed Express, Inc. (NASDAQ:PETS) Will Pay A US$0.30 Dividend In Four Days
BROKER RATINGS: Credit Suisse raises Next; Barclays lifts Croda
Frequently asked questionsWhat percentage of PetMed Express is owned by insiders or institutions?
Currently 3.606% of PetMed Express shares are held by insiders and 84.546% by institutions. How many people work for PetMed Express?
Latest data suggests 219 work at PetMed Express. When does the fiscal year end for PetMed Express?
PetMed Express's fiscal year ends in March. Where is PetMed Express based?
PetMed Express's address is: 420 South Congress Avenue, Delray Beach, FL, United States, 33445 What is PetMed Express's ISIN number?
PetMed Express's international securities identification number is: US7163821066 What is PetMed Express's CUSIP number?
PetMed Express's Committee on Uniform Securities Identification Procedures number is: 716382106
More guides on Finder
How to buy Argus Capital Corp (ARGU) stock when it goes public
Everything we know about the Argus Capital Corp IPO, plus information on how to buy in.
How to buy RenovoRx (RNXT) stock when it goes public
Everything we know about the RenovoRx IPO, plus information on how to buy in.
How to buy Draganfly (DPRO) stock when it goes public
Everything we know about the Draganfly IPO, plus information on how to buy in.
How to buy Society Pass Incorporated (SOPA) stock when it goes public
Everything we know about the Society Pass Incorporated IPO, plus information on how to buy in.
How to buy Guardforce AI Co (GFAI) stock when it goes public
Everything we know about the Guardforce AI Co IPO, plus information on how to buy in.
How to buy IsoPlexis Corporation (ISO) stock when it goes public
Everything we know about the IsoPlexis Corporation IPO, plus information on how to buy in.
How to buy Marpai (MRAI) stock when it goes public
Everything we know about the Marpai IPO, plus information on how to buy in.
How to buy DoubleDown Interactive (DDI) stock when it goes public
Everything we know about the DoubleDown Interactive IPO, plus information on how to buy in.
How to buy Omniq Corp (OMQS) stock when it goes public
Everything we know about the Omniq Corp IPO, plus information on how to buy in.
How to buy Mechanical Technology (MKTYP) stock when it goes public
Everything we know about the Mechanical Technology IPO, plus information on how to buy in.
Ask an Expert